Spanish Instituto de Salud Carlos III- Urgent request for expressions of interest for research projects on Sars-CoV-2 and disease COVID-19


Subsidy:  total budget available €24M

Deadline: expired

Consortium: Universities, other non-profit and for-profit (private) organisation can apply.

Scope: Proposals must be appropriate to the emergency situation and, therefore, allow immediate implementation and start-up in the National Health System, with concrete, early results applicable to the current situation. These proposals may be based on currently existing activities. The scope of these proposals may be:

  • Techniques for rapid virological diagnosis of SARS-CoV-2, industrially scalable and applicable to healthcare, with priority orientation towards the diagnosis of the early stages of infection in humans and that allow predicting severity for purposes of healthcare stratification.
  • Clinical-biological-molecular characterization of COVID-19 disease, stages, prognostic stratification and complications.
  • Development of innovative therapies, new antiviral, antiseptic and disinfectant molecules against SARS-CoV-2. Antiviral resistance studies. Effectiveness of non-pharmacological, prophylactic and therapeutic interventions.
  • Characterization of the SARS-CoV-2 virus, knowledge of the genetic and antigenic variation of SARS-CoV-2 as well as the immunological response to the SARS-CoV-2 virus and the virus-host interaction.
  • Vaccine development, efficacy and applicability.
  • Epidemiological surveillance of SARS-CoV-2 and molecular epidemiology: incidence of mortality and morbidity. Environmental and social factors of the spread. Risk factors and population dynamics of SARS-CoV-2 infection.
  • Socio-economic impact of the disease COVID-19. Use of primary care resources, general hospital resources, and critical care resources.
  • Artificial intelligence and massive analysis of integrated data oriented to the epidemiological control of the disease COVID-19.

Link to subsidy:

The subsidy landscape is responding quickly to the COVID-19 virus and the problems this crisis causes world-wide. A lot of new funding opportunities are being released to assist researchers and companies with their Research and Development activities against COVID-19. We have made an overview of all COVID-19 grants & funding opportunities. Check our COVID-19 Call Overview and stay up-to-date.

A more detailed and tailor-made overviews are available in 3 different products:

  1. Funding Scan. A summarized overview of funding opportunities for one specific R&D project with a short profile of the researcher or company. This includes a strategy with upcoming funding opportunities for the next year.
  2. Funding Advice. A detailed description of your company, research group, R&D projects and an overview of the timelines involved in future development. This includes a funding strategy for each project for the next 2 years.
  3. Funding Plan. A long-term funding strategy taking into consideration multiple R&D pillars. This detailed strategy focuses on multiple sources of funding and addresses financial weaknesses in continuing strategic planning.

Read more about it on our Strategic Funding Advice page.


Gain insights and accelerate the growth of your innovations. Sign-up to our monthly newsletter